G1 Therapeutics, Inc. (GTHX) Share-based Payment Arrangement, Expense USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
G1 Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • G1 Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.55 M, a 33.6% decline year-over-year.
  • G1 Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $13.2 M, a 29.2% decline year-over-year.
  • G1 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.5 M, a 29.5% decline from 2022.
  • G1 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.6 M, a 7.75% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.2 M $2.55 M -$1.29 M -33.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $14.5 M $3.21 M -$1.19 M -27.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $15.7 M $3.66 M -$1.13 M -23.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $16.8 M $3.81 M -$1.83 M -32.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $18.7 M $3.84 M -$1.93 M -33.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $20.6 M $4.4 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $4.79 M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $5.64 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $5.77 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q2 2017 $769 K +$451 K +142% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q2 2016 $318 K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.